IL-17A levels have also been associated with neutrophil expansion in CSF and disruption of the BBB, suggesting that Th17 cells may enhance and utilize glutamate excitotoxicity as an effector mechanism in the pathogenesis of MS (67). Here, IL17A is linked to myeloid sarcoma.